Yildirim, Zerrin
Delen, Firuze
Berron, David
Baumeister, Hannah
Ziegler, Gabriel
Schütze, Hartmut
Glanz, Wenzel
Dobisch, Laura
Peters, Oliver
Freiesleben, Silka Dawn
Schneider, Luisa-Sophie
Priller, Josef
Spruth, Eike Jakob
Schneider, Anja
Fliessbach, Klaus
Wiltfang, Jens
Schott, Björn-Hendrik
Meiberth, Dix
Buerger, Katharina
Janowitz, Daniel
Perneczky, Robert
Rauchmann, Boris-Stephan
Teipel, Stefan
Kilimann, Ingo
Laske, Christoph
Munk, Matthias H.
Spottke, Annika
Roy, Nina
Heneka, Michael
Brosseron, Frederic
Wagner, Michael
Roeske, Sandra
Ramirez, Alfredo
Ewers, Michael
Dechent, Peter
Hetzer, Stefan
Scheffler, Klaus
Kleineidam, Luca
Wolfsgruber, Steffen
Yakupov, Renat
Schmid, Matthias
Berger, Moritz
Gurvit, Hakan
Jessen, Frank
Duzel, Emrah
Funding for this research was provided by:
Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. (DZNE) in der Helmholtz-Gemeinschaft
Article History
Received: 19 October 2022
Accepted: 8 February 2023
First Online: 28 February 2023
Declarations
:
: All local institutional review boards and ethical committees approved the study protocol. All participants gave written informed consent before inclusion in the study. DELCODE is registered at the German Clinical Trials Register (DRKS00007966), (04/May/2015).
: Not applicable.
: The authors declare no competing interests.